Literature DB >> 30232737

In-flight cardiac arrest and in-flight cardiopulmonary resuscitation during commercial air travel: consensus statement and supplementary treatment guideline from the German Society of Aerospace Medicine-comment.

David Powell1, Martin Hudson2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30232737     DOI： 10.1007/s11739-018-1948-1

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  3 in total

1.  In-flight cardiac arrest and in-flight cardiopulmonary resuscitation during commercial air travel: consensus statement and supplementary treatment guideline from the German Society of Aerospace Medicine (DGLRM).

Authors:  Jochen Hinkelbein; Lennert Böhm; Stefan Braunecker; Harald V Genzwürker; Steffen Kalina; Fabrizio Cirillo; Matthieu Komorowski; Andreas Hohn; Jörg Siedenburg; Michael Bernhard; Ilse Janicke; Christoph Adler; Stefanie Jansen; Eckard Glaser; Pawel Krawczyk; Mirko Miesen; Janusz Andres; Edoardo De Robertis; Christopher Neuhaus
Journal:  Intern Emerg Med       Date:  2018-05-05       Impact factor: 3.397

2.  Prognostic Factors for Outcomes of In-Flight Sudden Cardiac Arrest on Commercial Airlines.

Authors:  Paulo M Alves; Charles A DeJohn; Eduard M Ricaurte; William D Mills
Journal:  Aerosp Med Hum Perform       Date:  2016       Impact factor: 1.053

3.  Cross-Sectional Survey of Physicians on Providing Volunteer Care for In-Flight Medical Events.

Authors:  Eric Chatfield; William F Bond; Bradley McCay; Claude Thibeault; Paulo M Alves; Marc Squillante; Joshua Timpe; Courtney J Cook; Raymond E Bertino
Journal:  Aerosp Med Hum Perform       Date:  2017-09-01       Impact factor: 1.053
  3 in total
  1 in total

1.  In-flight cardiac arrest and in-flight cardiopulmonary resuscitation during commercial air travel: consensus statement and supplementary treatment guideline from the German society of aerospace medicine (DGLRM): reply.

Authors:  J Hinkelbein; C Neuhaus
Journal:  Intern Emerg Med       Date:  2019-03-13       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.